Ibuprofen for neuroprotection after cerebral ischemia

Slides:



Advertisements
Similar presentations
Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Advertisements

Manuel J. Antunes, MD, PhD, DSc 
Aprotinin, but not ε-aminocaproic acid and tranexamic acid, exerts neuroprotection against excitotoxic injury in an in vitro neuronal cell culture model 
Differential neuronal vulnerability varies according to specific cardiopulmonary bypass insult in a porcine survival model  Nobuyuki Ishibashi, MD, Yusuke.
Intrinsic cardiac stem cells are essential for regeneration
Scan, plan, print, practice, perform: A disruptive technology?
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Simulation of single-ventricle physiology … a start
Abracadabra I, II…HeartMate 3?
Victor van Berkel, MD, PhD 
William M. DeCampli, MD, PhD 
Application of a neuroscience research model to study neuroprotection in children with congenital heart disease  Nobuyuki Ishibashi, MD, Richard A. Jonas,
Functional mitral stenosis after mitral valve repair is a true anatomic problem that originates from the time of surgery  Vincent Chan, MD, MPH, Thierry.
Philippe Menasché, MD, PhD 
Bicuspid aortic valve aortopathy: One size fits all?
Optimal dose of aprotinin for neuroprotection and renal function in a piglet survival model  Yusuke Iwata, MD, Toru Okamura, MD, Nobuyuki Ishibashi, MD,
Bigger The Journal of Thoracic and Cardiovascular Surgery
The lord of the rings  Antonio Miceli, MD, PhD 
Rodent brain slice model for the study of white matter injury
Aldo R. Castañeda, MD, PhD: Recipient of the Lifetime Achievement Award and 74th president of The American Association for Thoracic Surgery  Pedro J.
Franco Stella, MD, PhD, Francesco Petrella, MD 
The variability of the mitral valve anatomy and terminology
Yang Zhang, MD, Haiquan Chen, MD, PhD 
Main stem bronchus surgery with pulmonary preservation
Support Your Specialty
Innovation and science: The future of valve design
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
It's not “just a shunt” but sometimes it should be…
Military surgeons just want to have fun
Do we need a bibliometrician to know which way the wind is blowing?
A first start for lung transplantation?
Get it right the first time
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
Yusuke Takahashi, MD, PhD, Prasad S. Adusumilli, MD 
Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD 
Frank C. Spencer, MD, FACS, pioneering cardiothoracic surgeon
A fate worse than death  Jennifer S. Lawton, MD 
Attachment disorder in thoracoabdominal surgery
The Ross procedure: Time to reevaluate the guidelines
Manuel J. Antunes, MD, PhD, DSc 
Video-assisted resection for lung cancer results in fewer complications  Lunxu Liu, PhD, MD, FRCS  The Journal of Thoracic and Cardiovascular Surgery 
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
The thoracoabdominal saga and heroes
Patrick T. Roughneen, MD, Grant T. Fankhauser, MD, Abe DeAnda, MD 
T. Brett Reece, MD  The Journal of Thoracic and Cardiovascular Surgery 
If airlines can do it, we can too…
The origins of open heart surgery at the University of Minnesota 1951 to 1956  Richard A. DeWall, MD  The Journal of Thoracic and Cardiovascular Surgery 
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
The future of cardiac surgery training: A survival guide
The continuing challenge of congenital heart disease in China
Bicuspid aortopathy: Seeing the forest for the trees
Ralph E. Delius, MD  The Journal of Thoracic and Cardiovascular Surgery 
Should it stay or should it go?
The Journal of Thoracic and Cardiovascular Surgery
“The more things change…”: The challenges ahead
Toll-like receptor 4 inhibition attenuates ischemia-reperfusion injury in rats: Will it work in human beings?  Chadrick E. Denlinger, MD  The Journal.
Managing conflicts of interest
More than vital: Who bears the burden?
Respect the aorta The Journal of Thoracic and Cardiovascular Surgery
Proactive or reactive? Best approach to limb ischemia in peripheral venoarterial extracorporeal life support  Matthew C. Black, MD, Mark S. Slaughter,
Preoperative PFTs: The answer is blowing in the wind
Of mice and men… The Journal of Thoracic and Cardiovascular Surgery
Spinal cord protection via alpha-2 agonist-mediated increase in glial cell-line–derived neurotrophic factor  Kirsten A. Freeman, MD, David A. Fullerton,
Did you like Terminator 3 better than Terminator 2
How do we follow up our patients
Journal changes and initiatives
Zone zero thoracic endovascular aortic repair is all about “location, location, location”  Kevin L. Greason, MD  The Journal of Thoracic and Cardiovascular.
Calpain inhibitors: The aspirin of the 21st century?
Deciding how much to pay for effective care
Presentation transcript:

Ibuprofen for neuroprotection after cerebral ischemia Yusuke Iwata, MD, Olivier Nicole, PhD, David Zurakowski, PhD, Toru Okamura, MD, Richard A. Jonas, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 139, Issue 2, Pages 489-493 (February 2010) DOI: 10.1016/j.jtcvs.2009.05.049 Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 A, Sham wash (mixed cortical cultures). B, Ibuprofen (100 μg/mL) alone. C, Mixed cortical cultures were exposed to 12.5 μmol/L NMDA for 24 hours and demonstrated an acute swelling of neuronal cell bodies followed by a widespread necrotic neuronal degeneration resulting in disrupted neurons and segmentalized neuritis. D, Ibuprofen at a concentration of 100 μg/mL was co-applied in the medium with excitotoxin (NMDA). Ibuprofen preserved neuronal cells and protected neurites. Original magnification is 200×. Scale bars = 100 μm. NMDA, N-methyl-D-aspartate; Ib, ibuprofen. The Journal of Thoracic and Cardiovascular Surgery 2010 139, 489-493DOI: (10.1016/j.jtcvs.2009.05.049) Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Exposure to 12.5 μmol/L NMDA revealed approximately 70% neuronal cell death by LDH assay measuring LDH levels in bathing medium in both cultures. Ibuprofen at a concentration of 25 μg/mL, 50 μg/mL, and 100 μg/mL reduced neuronal cell death significantly from 74.5% ± 3.8% to 56.1% ± 4.0%, 38.7% ± 2.8%, and 12.3% ± 1.4% in mixed cultures, respectively, revealing a strong dose response (P < .001). However low-concentration ibuprofen failed to protect neurons in near-pure cultures. A, Mixed cultures. B, Near-pure cultures. *Significantly different from NMDA alone by analysis of variance with Tukey correction (mean ± standard error). The Journal of Thoracic and Cardiovascular Surgery 2010 139, 489-493DOI: (10.1016/j.jtcvs.2009.05.049) Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Exposure to 50 μmol/L kainate revealed approximately 30% neuronal cell death. Ibuprofen reduced neuronal cell death induced by exposure to 50 μmol/L kainate from 36.1% ± 3.5% to 20.0% ± 3.1% in mixed cultures but failed in near-pure cultures. A, Mixed cultures. B, Near-pure cultures. *Significantly different from kainate alone by analysis of variance with Tukey correction (mean ± standard error). The Journal of Thoracic and Cardiovascular Surgery 2010 139, 489-493DOI: (10.1016/j.jtcvs.2009.05.049) Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions